Saila Vikman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Saila Vikman has a total of 55 co-authors. Here are the top co-authors by number of shared publications:
- Kari Eino Juhani Airaksinen
Turku University Hospital and University of Turku
7 shared publications Ilkka Tierala
6 shared publicationsKari Niemelä
Heart Center, Tampere University Hospital, Finland
5 shared publications- Matti Niemelä
Department of Internal Medicine, Institute of Clinical Medicine, University of Oulu, P.O. Box 5000, Kajaanintie 50, Oulu FIN-90014, Finland
5 shared publications - Keijo Peuhkurinen
Oulu Deaconess Institute, Oulu, Finland
3 shared publications - Kirsi Majamaa-Voltti
Division of Cardiology, Department of Medicine, Oulu University Hospital, Finland
3 shared publications
Latest Publications
- 1 January 2009
- Vol. 125 (7) , 739-46
[Coronary artery disease in women].
Although the rate of coronary artery disease mortality has decreased over the last decades, it is still the leading cause of death in Finland. Coronary artery disease appears in women with a delay of ten years as compared with men. For women, diabetes and smoking increase the risk of developing the disease more than for men. Women's coronary arteries are smaller in size, which previously impaired the results of invasive treatment. Treatment outcome with current techniques is equal independently of gender. In spite of this, women in an acute attack of coronary artery disease are less frequently directed to coronary angiography.
- 1 January 2009
- Vol. 125 (7) , 739-46
[Coronary artery disease in women].
Although the rate of coronary artery disease mortality has decreased over the last decades, it is still the leading cause of death in Finland. Coronary artery disease appears in women with a delay of ten years as compared with men. For women, diabetes and smoking increase the risk of developing the disease more than for men. Women's coronary arteries are smaller in size, which previously impaired the results of invasive treatment. Treatment outcome with current techniques is equal independently of gender. In spite of this, women in an acute attack of coronary artery disease are less frequently directed to coronary angiography.
- 30 June 2007
- Published by Elsevier in International Journal of Cardiology
- Vol. 119, S10
Gender differences in the conservative treatment of acute coronary syndrome in Finland: Real-life data from the CONTACS-registry
- 30 June 2007
- Published by Elsevier in International Journal of Cardiology
- Vol. 119, S10
Gender differences in the conservative treatment of acute coronary syndrome in Finland: Real-life data from the CONTACS-registry
- 1 January 2007
- Published by Taylor & Francis in Scandinavian Cardiovascular Journal
- Vol. 41 (5) , 287-293
Gender-related differences in the management of non-ST-elevation acute coronary syndrome patients
Objectives. To compare management and outcome of female and male non-ST-elevation acute coronary syndrome (ACS) patients. Design. FINACS Studies are prospective registries of non-ST-elevation ACS patients conducted in 2001, 2003, and 2005 in nine hospitals. Results. The studies enrolled 1 399 patients from which 39% were women. During hospitalisation women were treated less often than men with aspirin (odds ratio [OR]) for women 0.60, 95% confidence interval [CI] 0.41 to 0.88, p=0.03). Women underwent less often in-hospital coronary angiography than men (adjusted OR 0.71, 95% CI 0.55 to 0.93, p=0.01). Also in the subgroup of younger (Conclusions. Compared to men women received less often aspirin. Women were referred less often to in-hospital coronary angiography. Under-use of in-hospital angiography was evident also in patients with high-risk features when guidelines recommend early invasive treatment.
- 1 January 2007
- Published by Taylor & Francis in Scandinavian Cardiovascular Journal
- Vol. 41 (5) , 287-293
Gender-related differences in the management of non-ST-elevation acute coronary syndrome patients
Objectives. To compare management and outcome of female and male non-ST-elevation acute coronary syndrome (ACS) patients. Design. FINACS Studies are prospective registries of non-ST-elevation ACS patients conducted in 2001, 2003, and 2005 in nine hospitals. Results. The studies enrolled 1 399 patients from which 39% were women. During hospitalisation women were treated less often than men with aspirin (odds ratio [OR]) for women 0.60, 95% confidence interval [CI] 0.41 to 0.88, p=0.03). Women underwent less often in-hospital coronary angiography than men (adjusted OR 0.71, 95% CI 0.55 to 0.93, p=0.01). Also in the subgroup of younger (Conclusions. Compared to men women received less often aspirin. Women were referred less often to in-hospital coronary angiography. Under-use of in-hospital angiography was evident also in patients with high-risk features when guidelines recommend early invasive treatment.
- 1 January 2005
- Vol. 121 (7) , 753-9
[Treatment and care of coronary artery syndrome in Finland].
- 13 September 2004
- Published by Wiley in Journal of Internal Medicine
- Vol. 256 (4) , 316-323
Improved adherence to practice guidelines yields better outcome in high‐risk patients with acute coronary syndrome without ST elevation: findings from nationwide FINACS studies
Abstract. Vikman S, Airaksinen KEJ, Tierala I, Peuhkurinen K, Majamaa‐Voltti K, Niemelä M, Tuunanen H, Nieminen MS, Niemelä K (Tampere University Hospital, Tampere; University of Turku, Turku; University of Helsinki, Helsinki; University of Kuopio, Kuopio; and University of Oulu, Oulu; Finland). Improved adherence to practice guidelines yields better outcome in high‐risk patients with acute coronary syndrome without ST elevation: findings from nationwide FINACS studies. J Intern Med 2004; 256: 316–323.Objectives. Treatment options for acute coronary syndrome (ACS) without ST elevation have evolved rapidly during the recent years, but the successful implementation of practice guidelines incorporating new treatments into practice has been challenging. In this study, we evaluate whether targeted educational intervention could improve adherence to treatment guidelines of ACS without ST elevation.Design, setting and subjects. A previous study, FINACS I, evaluated the treatment and outcome of 501 consecutive non‐ST elevation ACS patients that were referred in early 2001 to nine hospitals, covering nearly half of the Finnish population. That study revealed poor adherence to ESC guidelines, so targeted educational intervention on optimal practice was arranged before the second study (FINACS II), which was performed in the same hospitals using the same protocol as FINACS I. FINACS II, undertaken in early 2003, evaluated 540 consecutive patients.Interventions. Targeted educational programmes on optimal practice.Main outcome measures. The use of evidence‐based therapies in non‐ST elevation ACS patients. In‐hospital event‐free (death, new myocardial infarction, refractory angina, readmission with unstable angina and transient cerebral ischaemia/stroke) survival, and event‐free survival at 6 months.Results. Baseline characteristics and risk markers were similar in both studies, and no significant changes in resources were seen. In 2003, the in‐hospital use of statins, ACE‐inhibitors, clopidogrel and glycoprotein (GP) IIb/IIIa receptor antagonists increased significantly, and in‐hospital angiography was performed more often, especially in high‐risk patients (59% vs. 45%, P < 0.05); waiting time also shortened (4.2 ± 5.5 vs. 5.8 ± 4.7 days, P < 0.01). Overall no significant change was seen in the frequency of death either in‐hospital (2% vs. 4%, P = NS) or at 6 months (7% vs. 10%, P = NS) in FINACS II. However, the survival of high‐risk patients improved both in‐hospital (95% vs. 90%, P = 0.05) and at 6 months (89% vs. 78%, P = 0.05).Conclusion. In patients with non‐ST elevation ACS‐targeted educational interventions appeared to be associated with improved adherence to practical guidelines, which yielded a better outcome in high‐risk ACS patients.
- 13 September 2004
- Published by Wiley in Journal of Internal Medicine
- Vol. 256 (4) , 316-323
Improved adherence to practice guidelines yields better outcome in high‐risk patients with acute coronary syndrome without ST elevation: findings from nationwide FINACS studies
Abstract. Vikman S, Airaksinen KEJ, Tierala I, Peuhkurinen K, Majamaa‐Voltti K, Niemelä M, Tuunanen H, Nieminen MS, Niemelä K (Tampere University Hospital, Tampere; University of Turku, Turku; University of Helsinki, Helsinki; University of Kuopio, Kuopio; and University of Oulu, Oulu; Finland). Improved adherence to practice guidelines yields better outcome in high‐risk patients with acute coronary syndrome without ST elevation: findings from nationwide FINACS studies. J Intern Med 2004; 256: 316–323.Objectives. Treatment options for acute coronary syndrome (ACS) without ST elevation have evolved rapidly during the recent years, but the successful implementation of practice guidelines incorporating new treatments into practice has been challenging. In this study, we evaluate whether targeted educational intervention could improve adherence to treatment guidelines of ACS without ST elevation.Design, setting and subjects. A previous study, FINACS I, evaluated the treatment and outcome of 501 consecutive non‐ST elevation ACS patients that were referred in early 2001 to nine hospitals, covering nearly half of the Finnish population. That study revealed poor adherence to ESC guidelines, so targeted educational intervention on optimal practice was arranged before the second study (FINACS II), which was performed in the same hospitals using the same protocol as FINACS I. FINACS II, undertaken in early 2003, evaluated 540 consecutive patients.Interventions. Targeted educational programmes on optimal practice.Main outcome measures. The use of evidence‐based therapies in non‐ST elevation ACS patients. In‐hospital event‐free (death, new myocardial infarction, refractory angina, readmission with unstable angina and transient cerebral ischaemia/stroke) survival, and event‐free survival at 6 months.Results. Baseline characteristics and risk markers were similar in both studies, and no significant changes in resources were seen. In 2003, the in‐hospital use of statins, ACE‐inhibitors, clopidogrel and glycoprotein (GP) IIb/IIIa receptor antagonists increased significantly, and in‐hospital angiography was performed more often, especially in high‐risk patients (59% vs. 45%, P < 0.05); waiting time also shortened (4.2 ± 5.5 vs. 5.8 ± 4.7 days, P < 0.01). Overall no significant change was seen in the frequency of death either in‐hospital (2% vs. 4%, P = NS) or at 6 months (7% vs. 10%, P = NS) in FINACS II. However, the survival of high‐risk patients improved both in‐hospital (95% vs. 90%, P = 0.05) and at 6 months (89% vs. 78%, P = 0.05).Conclusion. In patients with non‐ST elevation ACS‐targeted educational interventions appeared to be associated with improved adherence to practical guidelines, which yielded a better outcome in high‐risk ACS patients.
- 1 January 2003
- Published by Taylor & Francis in Annals of Medicine
- Vol. 35 (1) , 36-42
Heart rate variability and recurrence of atrial fibrillation after electrical cardioversion
BACKGROUND: Heart rate (HR) variability has been shown to predict spontaneous onset of atrial fibrillation (AF). This study was designed to test the hypothesis that HR variability after electrical cardioversion (CV) of persistent AF predicts the recurrence of AF. METHODS: Various time and frequency domain measures of HR variability, along with the non‐linear measures of HR dynamics, were analyzed from the 24‐hour ECG recordings in 78 patients with persistent AF after restoration of sinus rhythm with electrical CV. RESULTS: During the follow‐up of one month, 27 patients (35%) had recurrence of AF. The patients with AF recurrence had significantly higher standard deviation of all R‐R intervals (SDNN 117 ± 34versus100 ± 29P < 0.05), increased high‐frequency (lnHF 5.7 ± 0.6versus5.3 ± 0.7P < 0.05 ), low‐frequency (lnLF 6.2 ± 0.8versus5.6 ± 0.9P < 0.01) and very‐low‐frequency (InVLF 7.1 ± 0.8versus6.5 ± 0.8P < 0.01) power spectral components of HR variability than those who remained in sinus rhythm. Approximate entropy, a measure of complexity of HR dynamics, and the short‐term fractal scaling exponent did not differ between the groups, but the long‐term power‐law slope β was steeper among the patients who remained in sinus rhythm ( P < 0.05). During the first week after the CV, increased HF power (highest tertile) was the most powerful predictor of AF recurrence with odds ratio of 2.8 (95% confidence interval 1.0 to 8.0,P < 0.05). Increased VLF power spectral component at baseline predicted best the late recurrence of AF with odds ratio of 3.3 (95% confidence interval 1.6 to 7.2,P < 0.01). No clinical or echocardiographic variable predicted the recurrence of AF. CONCLUSIONS: Increased HR variability in all major power spectral bands is associated with late recurrence of AF after electrical CV. Enhanced cardiac vagal outflow, reflected as an increased HF power spectral component, seems to predict specifically the early recurrence of AF after the CV.
- 1 January 2003
- Published by Taylor & Francis in Annals of Medicine
- Vol. 35 (1) , 36-42
Heart rate variability and recurrence of atrial fibrillation after electrical cardioversion
BACKGROUND: Heart rate (HR) variability has been shown to predict spontaneous onset of atrial fibrillation (AF). This study was designed to test the hypothesis that HR variability after electrical cardioversion (CV) of persistent AF predicts the recurrence of AF. METHODS: Various time and frequency domain measures of HR variability, along with the non‐linear measures of HR dynamics, were analyzed from the 24‐hour ECG recordings in 78 patients with persistent AF after restoration of sinus rhythm with electrical CV. RESULTS: During the follow‐up of one month, 27 patients (35%) had recurrence of AF. The patients with AF recurrence had significantly higher standard deviation of all R‐R intervals (SDNN 117 ± 34versus100 ± 29P < 0.05), increased high‐frequency (lnHF 5.7 ± 0.6versus5.3 ± 0.7P < 0.05 ), low‐frequency (lnLF 6.2 ± 0.8versus5.6 ± 0.9P < 0.01) and very‐low‐frequency (InVLF 7.1 ± 0.8versus6.5 ± 0.8P < 0.01) power spectral components of HR variability than those who remained in sinus rhythm. Approximate entropy, a measure of complexity of HR dynamics, and the short‐term fractal scaling exponent did not differ between the groups, but the long‐term power‐law slope β was steeper among the patients who remained in sinus rhythm ( P < 0.05). During the first week after the CV, increased HF power (highest tertile) was the most powerful predictor of AF recurrence with odds ratio of 2.8 (95% confidence interval 1.0 to 8.0,P < 0.05). Increased VLF power spectral component at baseline predicted best the late recurrence of AF with odds ratio of 3.3 (95% confidence interval 1.6 to 7.2,P < 0.01). No clinical or echocardiographic variable predicted the recurrence of AF. CONCLUSIONS: Increased HR variability in all major power spectral bands is associated with late recurrence of AF after electrical CV. Enhanced cardiac vagal outflow, reflected as an increased HF power spectral component, seems to predict specifically the early recurrence of AF after the CV.
- 1 January 2003
- Vol. 119 (5) , 369-71
[New challenges in diagnostics and therapy of acute coronary syndromes].
- 1 January 2003
- Vol. 119 (5) , 369-71
[New challenges in diagnostics and therapy of acute coronary syndromes].
- 1 January 2003
- Vol. 119 (14) , 1313-20
[Treatment of acute coronary syndrome in Finland].